Given the global prevalence of prostate cancer in men, it is crucial to explore more effective
treatment strategies. Recently, immunotherapy has emerged as a promising cancer …

Advances in cancer therapeutics have improved patient survival rates. However, cancer
survivors may suffer from adverse events either at the time of therapy or later in life …

Head and neck squamous cell carcinoma (HNSCC) remain a major oncological challenge
with significant morbidity and mortality rates. Erlotinib (Er) and Curcumin (Cm) are potential …

Background Head and neck squamous cell carcinoma (HNSCC) is an extremely
heterogeneous and metastatic disease. Anoikis, which is a specific type of programmed …

Head and neck cancer (HNSCC) is the 8th most common cancer in the UK, with incidence
increasing due to lifestyle factors such as tobacco and alcohol abuse. HNSCC is an immune …

With the emergence of targeted inhibition strategies for Hedgehog signaling in cancer,
multiple Hedgehog signaling pathway-related biomarkers have become the focus of …

Objectives The management of inoperable oral cavity squamous cell carcinoma (OC-SCC)
is onerous. We aimed to retrospectively analyse the outcome of our cohort of inoperable OC …

Radiotherapy (RT) is a common treatment for head and neck tumors. However, it causes
several physical and behavioral side effects, and no study has assessed the emotional …

Head and neck squamous cell carcinoma (HNSCC) is a type of head and neck cancer that is
aggressive, difficult to treat, and often associated with poor prognosis. HNSCC is the sixth …

According to current predictions, one‑fifth of all Americans will develop skin cancer during
their lifetime. Cutaneous squamous cell carcinoma (cSCC) most commonly occurs in the …